Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico.
NPJ Vaccines. 2023 May 10;8(1):67. doi: 10.1038/s41541-023-00662-6.
NPJ Vaccines. 2023.
PMID: 37164959
Free PMC article.
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs.
Lara-Puente JH, Carreño JM, Sun W, Suárez-Martínez A, Ramírez-Martínez L, Quezada-Monroy F, Paz-De la Rosa G, Vigueras-Moreno R, Singh G, Rojas-Martínez O, Chagoya-Cortés HE, Sarfati-Mizrahi D, Soto-Priante E, López-Macías C, Krammer F, Castro-Peralta F, Palese P, García-Sastre A, Lozano-Dubernard B.
Lara-Puente JH, et al. Among authors: sarfati mizrahi d.
mBio. 2021 Oct 26;12(5):e0190821. doi: 10.1128/mBio.01908-21. Epub 2021 Sep 21.
mBio. 2021.
PMID: 34544278
Free PMC article.
Item in Clipboard
Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D, Lozano-Dubernard B, Soto-Priante E, Castro-Peralta F, Flores-Castro R, Loza-Rubio E, Gay-Gutiérrez M.
Sarfati-Mizrahi D, et al.
Avian Dis. 2010 Mar;54(1 Suppl):239-41. doi: 10.1637/8735-032509-Reg.1.
Avian Dis. 2010.
PMID: 20521638
Item in Clipboard
Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
Lozano-Dubernard B, Soto-Priante E, Sarfati-Mizrahi D, Castro-Peralta F, Flores-Castro R, Loza-Rubio E, Gay-Gutiérrez M.
Lozano-Dubernard B, et al. Among authors: sarfati mizrahi d.
Avian Dis. 2010 Mar;54(1 Suppl):242-5. doi: 10.1637/8767-033109-ResNote.1.
Avian Dis. 2010.
PMID: 20521639
Clinical Trial.
Item in Clipboard
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico.
Ponce-de-León S, Torres M, Soto-Ramírez LE, Calva JJ, Santillán-Doherty P, Carranza-Salazar DE, Carreño JM, Carranza C, Juárez E, Carreto-Binaghi LE, Ramírez-Martínez L, Paz-De la Rosa G, Vigueras-Moreno R, Ortiz-Stern A, López-Vidal Y, Macías AE, Torres-Flores J, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Kawabata H, González-Domínguez I, Martínez-Guevara JL, Sun W, Sarfati-Mizrahi D, Soto-Priante E, Chagoya-Cortés HE, López-Macías C, Castro-Peralta F, Palese P, García-Sastre A, Krammer F, Lozano-Dubernard B.
Ponce-de-León S, et al. Among authors: sarfati mizrahi d.
medRxiv [Preprint]. 2022 Feb 9:2022.02.08.22270676. doi: 10.1101/2022.02.08.22270676.
medRxiv. 2022.
PMID: 35169806
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite